LAG3 and hepatocellular carcinoma: To further confirm the effect of Oxysophocarpine treatment alone and combined with anti‐Lag‐3 immunotherapy against HCC in vivo, C57BL/6 mice burdened with Hepa1‐6 subcutaneous tumor were used.